Los Angeles Capital Management LLC Has $45.07 Million Holdings in CME Group Inc. (NASDAQ:CME)

Los Angeles Capital Management LLC raised its holdings in CME Group Inc. (NASDAQ:CME) by 39.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 204,238 shares of the financial services provider’s stock after buying an additional 58,037 shares during the quarter. Los Angeles Capital Management LLC owned 0.06% of CME Group worth $45,065,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in CME. Y.D. More Investments Ltd bought a new stake in shares of CME Group during the second quarter valued at approximately $36,000. McClarren Financial Advisors Inc. increased its holdings in shares of CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares in the last quarter. Asset Dedication LLC grew its holdings in CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. grew its holdings in CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after buying an additional 74 shares in the last quarter. Finally, Bank & Trust Co bought a new stake in CME Group during the second quarter worth $76,000. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Price Performance

CME traded up $3.62 during trading on Friday, reaching $225.66. 1,798,000 shares of the company were exchanged, compared to its average volume of 1,483,283. The company’s 50-day moving average is $221.72 and its two-hundred day moving average is $209.86. The company has a market cap of $81.26 billion, a price-to-earnings ratio of 23.73, a P/E/G ratio of 5.56 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.36.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.25 EPS. Research analysts forecast that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be paid a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.04%. CME Group’s dividend payout ratio is currently 48.37%.

Wall Street Analysts Forecast Growth

CME has been the subject of several recent research reports. Piper Sandler upped their price target on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Monday, October 28th. Oppenheimer upped their price target on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. JPMorgan Chase & Co. upped their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research note on Tuesday, October 8th. Finally, TD Cowen started coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective for the company. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, CME Group has a consensus rating of “Hold” and a consensus price target of $222.73.

Insider Activity

In other news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is currently owned by insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.